Catalan Institute of Oncology (ICO)
If you are the contact person for this centre and you wish to make any changes, please contact us.
Medical Oncologist at the Catalan Institute of Oncology (ICO
Medical oncologist at the Catalan Institute of Oncology in Girona
Director of Epidemiology, Prevention and Cancer Control at the Catalan Institute of Oncology and Director of the WHO Collaborating Centre for Tobacco Control at the Catalan Institute of Oncology
Head of the Haematology Department at ICO Badalona
Epidemiologist at the Girona Cancer Epidemiology and Registry Unit of the Catalan Institute of Oncology - Oncology Master Plan
Head of Medical Oncology and Director General of the Catalan Institute of Oncology (ICO).
Emeritus researcher at the Catalan Institute of Oncology (ICO), senior researcher at the Bellvitge Biomedical Research Institute (IDIBELL) and lecturer in the Faculty of Health Sciences at the Universitat Oberta de Catalunya (UOC)
A study published in JAMA Network Open has followed 1,340 women with high-risk operable breast cancer. Analysing their lifestyles before, during and after treatment, the researchers conclude that those who followed a healthier pattern - including physical activity, no smoking, high fruit and vegetable intake, and low consumption of meat and sugary drinks - had a 37% lower risk of relapse and a 58% higher chance of survival than those who followed a worse pattern. Although the improvements in absolute risk were much smaller, the authors conclude that "lifestyle interventions may be a safe, inexpensive and feasible adjuvant strategy to delay and prevent recurrence and death from the world's most common cancer".
A phase 2 clinical trial has analysed the safety and efficacy of adding immunotherapy to traditional chemotherapy to treat a subtype of acute lymphoblastic leukaemia in children under one year of age. This subtype of leukaemia, although rare in absolute terms, is the most common in children of this age, and its prognosis in this age group had not improved in recent years. The immunotherapy used, a bispecific antibody that binds to tumour cells on the one hand and T lymphocytes on the other, improved two-year survival from 66% to 93% in treated patients, according to The New England Journal of Medicine (NEJM).
Un estudio ha estimado las muertes por cáncer que se producirán en la Unión Europea y el Reino Unido en 2023. Comparándolas con las observadas en 2018, estiman que se reducirán en un 6,5 % en hombres y un 3,7 % en mujeres de forma global. Sin embargo, en España aumentará la mortalidad por cáncer de pulmón en mujeres. Los resultados se publican en la revista Annals of Oncology.
A phase 2 clinical trial has tested a type of immunotherapy based on oncolytic viruses in combination with chemotherapy for the treatment of triple-negative breast tumours. The results are published in the journal Nature Medicine.
Research to be published in the journal Nature identifies and characterizes the cells responsible for relapse in colon cancer. In addition, it proposes revising clinical guidelines and administering immunotherapy before surgery to try to avoid them
A meta-analysis published in the journal PLOS Medicine has analysed the time to diagnosis and treatment of various types of cancer in rich and poor countries. On average, the processes are 1.5 to 4 times slower in disadvantaged countries.
In an interview on TV3's Els Matins, the Catalan government's health minister Josep Maria Argimon explained that they are preparing a regulation to ban smoking on bar terraces and make them "smoke-free spaces". They are also considering adding canopies and the entrances and exits of schools to the ban.
In the United States, the human papillomavirus vaccine began to be recommended in 2006 for girls aged 9-26 years. A study published in the journal JAMA Health Forum concludes that the campaign significantly reduced the risk of HPV infection in vaccinated women. In addition, herd immunity reduced the likelihood of infection in unvaccinated women.
A study published in The Lancet finds that 44.4% of cancer deaths worldwide are due to preventable risk factors, especially smoking, alcohol consumption and being overweight.